These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3828020)

  • 21. [Cerebral hemorrhage associated with phenylpropanolamine].
    Strand OA; Lund-Tønnesen S; Sortland O
    Tidsskr Nor Laegeforen; 1991 May; 111(12):1490-2. PubMed ID: 2042180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-the-counter stroke?
    Ornato JP
    Health News; 2000 Dec; 6(12):3. PubMed ID: 11142938
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenylpropanolamine and the risk of hemorrhagic stroke.
    Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI
    N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebral hemorrhage associated with the use of phenylpropanolamine. Clinical cases].
    Tapia J
    Rev Med Chil; 1996 Dec; 124(12):1499-503. PubMed ID: 9334487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant.
    Smookler S; Bermudez AJ
    Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PPA blues. What do you do when scientists tell you that the bottles in your medicine chest can kill you?
    Smith IK
    Time; 2000 Oct; 156(18):101. PubMed ID: 11185359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Stroke and phenylpropanolamine: what risk factors and what recommendations in request?].
    Die-Kacou H; Kamagaté M; Daubrey-Potey TH; Bamba-Kamagaté D; Yavo JC; Balayssac E; Gboignon VM; Kakou KA; Gilbernaire AF
    Dakar Med; 2007; 52(1):56-7. PubMed ID: 19102094
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
    Graf P; Toll K; Palm J; Hallén H
    Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylpropanolamine and associated myocardial injury.
    Leo PJ; Hollander JE; Shih RD; Marcus SM
    Ann Emerg Med; 1996 Sep; 28(3):359-62. PubMed ID: 8780486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylpropanolamine and other over-the-counter vasoactive compounds.
    Bravo EL
    Hypertension; 1988 Mar; 11(3 Pt 2):II7-10. PubMed ID: 3280497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
    Greenway F; Herber D; Raum W; Herber D; Morales S
    Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylpropanolamine-induced hypertensive seizures.
    Howrie DL; Wolfson JH
    J Pediatr; 1983 Jan; 102(1):143-5. PubMed ID: 6848713
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenylpropanolamine-induced psychosis. Potential predisposing factors.
    Marshall RD; Douglas CJ
    Gen Hosp Psychiatry; 1994 Sep; 16(5):358-60. PubMed ID: 7995508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylpropanolamine-associated CNS complications in children and adolescents.
    Bale JF; Fountain MT; Shaddy R
    Am J Dis Child; 1984 Jul; 138(7):683-5. PubMed ID: 6428218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurologic signs and symptoms related to over-the-counter diet pills.
    Mueller SM; Graham JD; Duggan D
    Indiana Med; 1985 May; 78(5):388-90. PubMed ID: 3998456
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute dystonia following standard doses of a cold medicine containing phenylpropanolamine.
    Heath HW; Allen JK
    Clin Pediatr (Phila); 1997 Jan; 36(1):57-8. PubMed ID: 9007349
    [No Abstract]   [Full Text] [Related]  

  • 39. Case-control study was springboard for phenylpropanolamine action.
    Miller JL
    Am J Health Syst Pharm; 2000 Dec; 57(24):2254-5. PubMed ID: 11146967
    [No Abstract]   [Full Text] [Related]  

  • 40. Cerebral infarction after excessive use of nasal decongestants.
    Montalbán J; Ibañez L; Rodriguez C; Lopez M; Sumalla J; Codina A
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):541-3. PubMed ID: 2738602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.